Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8167001rdf:typepubmed:Citationlld:pubmed
pubmed-article:8167001lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:8167001lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:8167001lifeskim:mentionsumls-concept:C1332034lld:lifeskim
pubmed-article:8167001lifeskim:mentionsumls-concept:C0032150lld:lifeskim
pubmed-article:8167001lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:8167001lifeskim:mentionsumls-concept:C1424810lld:lifeskim
pubmed-article:8167001lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:8167001pubmed:issue1lld:pubmed
pubmed-article:8167001pubmed:dateCreated1994-6-1lld:pubmed
pubmed-article:8167001pubmed:abstractTextA mixture of Plasmodium falciparum exoantigens inducing lymphocyte activation and cytokine production was shown to contain the malaria vaccine candidate, the serine-stretch protein. This protein was shown serologically to correspond to Ag2, an exoantigen recognized by antibodies linked with protection against malaria. The glycophorin-binding protein, the histidine-rich protein II, the S-antigen, the heat shock protein 70, the ring-infected erythrocyte surface antigen, and the apical membrane antigen-1 were also shown serologically to be present in the mixture of exoantigens.lld:pubmed
pubmed-article:8167001pubmed:languageenglld:pubmed
pubmed-article:8167001pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:citationSubsetIMlld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8167001pubmed:statusMEDLINElld:pubmed
pubmed-article:8167001pubmed:monthJanlld:pubmed
pubmed-article:8167001pubmed:issn0903-4641lld:pubmed
pubmed-article:8167001pubmed:authorpubmed-author:HundtEElld:pubmed
pubmed-article:8167001pubmed:authorpubmed-author:KnappBBlld:pubmed
pubmed-article:8167001pubmed:authorpubmed-author:HansenM BMBlld:pubmed
pubmed-article:8167001pubmed:authorpubmed-author:JakobsenP HPHlld:pubmed
pubmed-article:8167001pubmed:issnTypePrintlld:pubmed
pubmed-article:8167001pubmed:volume102lld:pubmed
pubmed-article:8167001pubmed:ownerNLMlld:pubmed
pubmed-article:8167001pubmed:authorsCompleteYlld:pubmed
pubmed-article:8167001pubmed:pagination53-8lld:pubmed
pubmed-article:8167001pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:meshHeadingpubmed-meshheading:8167001-...lld:pubmed
pubmed-article:8167001pubmed:year1994lld:pubmed
pubmed-article:8167001pubmed:articleTitleSerine-stretch protein (SERP) of Plasmodium falciparum corresponds to the exoantigen Ag2, a target of antibodies associated with protection against malaria.lld:pubmed
pubmed-article:8167001pubmed:affiliationUniversity of Copenhagen, Department of Infectious Diseases, Denmark.lld:pubmed
pubmed-article:8167001pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8167001pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed